New FDA Initiatives Aim to Spur Innovation

August 2, 2003
Jill Wechsler
Jill Wechsler

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Pharmaceutical Technology, Pharmaceutical Technology-08-02-2003, Volume 27, Issue 8

Manufacturers face challenges from FDA's plans to streamline the drug review and development processes aimed to spur innovation.